IQ-AI, Ltd.

IQ-AI, Ltd.

  • News & Announcements
  • Shareholder Information
  • Investor Relations
  • Significant Shareholders
  • Publications
  • Home
  • Corporate News & Announcements
  • IQ-AI News & Announcements
  • IQ-AI shares cease trading on the OTCQB
 

BLOG

IQ-AI
Tuesday, 19 September 2023 / Published in IQ-AI News & Announcements

IQ-AI shares cease trading on the OTCQB

/**/
RNS Number : 9599M
IQ-AI Limited
19 September 2023
 

19 September 2023

IQ-AI Limited

(“IQ-AI” or the “Company”)

 

IQ-AI shares cease trading on the OTCQB Venture Market in the United States

 

Further to the announcement of 1 September 2021, IQ-AI Limited (LSE: IQAI) has decided to cease trading on the OTCQB Venture Market (“OTCQB”) in the United States as there has been no trading on this market since November 2022. Henceforth, IQ-AI will explore other more suitable markets and remain focused on its listing on the Main Market of the London Stock Exchange.

 

For the avoidance of any doubt, removal from trading on the OTCQB market will have no impact on the IQ-AI ordinary shares admitted to listing on the London Stock Exchange’s Main Market under the symbol “IQAI”.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

IQ-AI Limited

Trevor Brown/ Vinod Kaushal/Brett Skelly/Michael Schmainda

 

0207 469 0930

 

Peterhouse Capital Limited

Duncan Vasey/Heena Karani

 

0207 220 9797

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Article source
  • Tweet

What you can read next

AI Metrics and Imaging Biometrics Strike Agreement
IMAGING BIOMETRICS UPGRADES IB CLINIC SOFTWARE
Keck Medical Center of USC Installs Imaging Biometrics’ Software

Recent Posts

  • Reduced Gadolinium Approach Validated’

    /**/ RNS Number : 7871L IQ-AI Limited 08 Septem...
  • Update on Collaboration Agreement with Mayo Clinic

    /**/ RNS Number : 8096J IQ-AI Limited 18 August...
  • IB & GE HealthCare Enter into Commercial Agreement

    /**/ RNS Number : 8077J IQ-AI Limited 18 August...
  • Half-year Report

    /**/ RNS Number : 5460J IQ-AI Limited 17 August...
  • Orphan Drug Designation for GaM in Pediatric GBM

    /**/ RNS Number : 8411F IQ-AI Limited 13 July 2...
  • Policies
  • Investor Information

iq-ai@imagingbiometrics.com

P. O. Box 264
Forum 4, Grenville Street
St Helier, Jersey, Channel Islands
JE4 8TQ

Copyright © 2015-2023 IQ-AI. All Rights Reserved
TOP
Our website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptReject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT